CAR NKT cells, a promising step forward in the treatment of solid tumors
An ongoing clinical trial shows that human CAR NKT cells are safe and, in 1 of 3 patients, induced regression of metastatic lesions.
Read More
solid tumors
Special delivery of IL-7 signaling makes all the difference for CAR T cells fighting solid tumors
Since he was in college, Thomas Shum wanted to pursue a career in cancer research. As he advanced in his studies, he was able to
Read More